Tekla Life Sciences Investors (HQL)

US · Financial Services · Asset Management

$16.78-2.67%

Last close · 2026-10-16

Latest quarter · ended 2026-03-31

Revenue

$48.1M

Revenue YoY

+2227.6%

Net profit

$65.3M

Profit YoY

+30.0%

Net margin

135.9%

Key statistics

Market cap

$534.0M

P/E

2.6

Forward P/E

0.0

P/B

1.06

Book value

$18.44

EPS (TTM)

$6.64

Dividend yield

10.88%

52-week high

$22.04

52-week low

$13.85

50-day MA

$20.05

200-day MA

$18.18

Beta

0.73

Shareholding

Insiders

0.00%

Institutions

26.77%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tekla Life Sciences Investors — free to start.

Open in the app Google Play App Store

Other Financial Services companies

Berkshire Hathaway Inc Berkshire Hathaway Inc JPMorgan Chase & Co Visa Inc. Class A Mastercard Inc Bank of America Corp HSBC Holdings PLC ADR Morgan Stanley Royal Bank of Canada Goldman Sachs Group Inc Wells Fargo & Company Mitsubishi UFJ Financial Group Inc ADR

Data updated 2026-10-18.